Toll like receptor (TLR), one of the key functions of innate immune system, can recognize not only exogenous pathogenassociated molecular patterns, namely PAMPs, but also endogenous molecules created upon tissue injury, sterile inflammation and degeneration. Endogenous TLR ligands are called as damage-associated molecular patters (DAMPs), including endogenous molecules released by activated and necrotic cells, and extracellular matrix molecules. DAMPs are also known as alarmins. TLR research has brought about new insights in the rheumatic diseases. Previous reports suggest that TLRs and the signal pathways intensively contribute to the pathogenesis of rheumatoid arthritis (RA) and other arthritic conditions with interaction of various TLR ligands. Accumulated knowledge of TLR system is summarized to overlook TLRs and the signaling pathway in arthritis conditions, with special reference to RA. 〔J Clin Exp Hematopathol 51(2) : 77-92, 2011〕 
INTRODUCTION
Rheumatoid arthritis (RA) is one of the terrible disasters of musculoskeletal system, like repeated tsunami attacking joints by conscious or unconscious manner. If timely therapy fails to calm disease activity down, persistent inflammation leads to severe bone and joint destruction, often combined with serious extraarticular manifestations. Inflammation has been recognized as one of the host immune responses to both internal and external threats. Various mediators have been identified and linked to the physiologic and pathologic roles of inflammation. Complicated inflammatory reactions found in RA are not merely incidental, but rather, drive and define the pathologic state. Better understanding of molecular and cellular mechanisms responsible for inflammation would provide patients with RA relief from pain and disability. The pathogenesis of RA is probably attributed to interplay of genetic and environmental factors, in which immune response plays a central role. However, in spite of intensive research, the precise mechanism is not elucidated yet, and the studies often have been apt to focus on the system of adaptive immunity rather than innate one.
Immune response is induced by not only microbial infection, but also sterile tissue damage and degeneration. This paradox was first explained by Matzieger in 1994, who proposed that immune system is designed to fight with both external and internal dangers, rather than mediate recognition of non-self over self. 1 The following question was how organisms recognized and efficiently responded to the dangers. Three main families of sensing molecules, termed "pattern recognition receptors (PRRs)", have been identified to give the answer. Mammalian cells can sense danger signals from both pathogens and damaged tissues via PRRs of innate immune system, which evolved earlier than the highly diverse receptors of adaptive immune system equipped in vertebrate. The innate sensors include Toll-like receptors (TLRs), retinoid acid inducible gene (RIG)-I like receptors (RLRs), and nucleotide-binding oligomelization domain (NOD)-like receptors (NLRs) ( Table 1 ). All the abbreviations of the molecules and related structures used in this review were summarized alphabetically in the Appendix. TLRs are located on the cellsurface and endosome. They can sense exogenous "pathogen-associated molecular patterns (PAMPs)" 2 and endogenous "damage-associated molecular patterns (DAMPs)". They are also known as alarmins. 3, 4 RLRs are cytosolic sensors for nucleic acids. RIG-1 and MAD5 can sense RNA species. DAI recognize DNAs. NLRs include NOD-1,sensors can promote either the activation and nuclear translocation of transcription factors (IRF, NF-kB and AP-1) that derive expression of cytokines, such as IFNa/b, TNF and proIL-1b, or the assembly of the caspase-1 inflammasome and subsequent maturation of IL-1b from proIL-1b [5] [6] [7] [8] (Fig. 1 ). The host responses via the sensors initially can work to eliminate infection and are beneficial in most cases, but the defective regulation may result in autoimmune and/or autoinflammatory responses, many of which present rheumatic manifestations. 6 Essential keys of autoimmune response include the nature and relative contribution of endogenous versus exogenous stimuli, the abnormalities that override the normal discrimination between self and foreign antigens, and the interplay between innate and adaptive immune systems. RA and systemic lupus erythematosus (SLE) are representative diseases. Recognition of self nucleic acids by TLRs seems to be the major pathogenetic mechanism in SLE. In RA, recognitions of products from microbes and damaged tissues by the TLRs and other innate sensors are likely to contribute the pathogenesis. By contrast, several genetic mutations, that either provoke or permit uncontrolled activation of the innate immune system, can trigger "autoinflammation", in which IL-1b disorders including NLRP3/ASC/capase-1 (IL-1 convertase) and their related pathway play a major role. They often accompany with rheumatic manifestations with arthritis, i.e., Blau syndrome, cryopyinopathies, familial Mediterranean fever, and pyogenic arthritis with pyoderma gangrenosum. Excessive deposition of crystal also induces the host reaction as a result of autoinflammatory reaction, seen such as gout and pseudogout. Psoriatic arthritis, systemic-onset juvenile idiopathic arthritis, adult-onset Still's disease, Schnitzler syndrome and Gaudaloupe variant periodic fever syndrome are categorized as possible candidates of autoinflammatory diseases. 6, [8] [9] [10] Recent TLR research has brought about new insights in the pathogenesis of many rheumatic diseases. Moreover, possible mechanism of collaboration and cross-talk among innate immune sensors have been discussed. Increase level of cryopyrin, which is linked to caspase-1 and one of central components of inflammasome, was identified in RA synovium.
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Biglycan, one of extracellular matrix components in cartilage, also increased 12,13 and activated NLRP3 inflammasome via TLR2 and TLR4.
14 RA, psoriatic arthritis, Blau syndrome and gout are the possible candidates, involving interplay of the sensors.
10,15-17 In this review, accumulated knowledge of TLRs and the signaling is summarized with discussions of possible pathogenesis of arthritis, with a special reference to RA.
TLRs AND PAMPs
Toll receptor was originally identified in Drosophila melanogaster as a receptor essential for the establishment of the dorso-ventral pattern in developing embryos. 18 In 1996, Hoffmann and Lemaitre demonstrated that Toll-mutant flies were highly susceptible to fungal infections. 19 A mammalian toll homologue was first reported in 1997 and named TLR.
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TLRs belong to the family of PRRs, and consist of main innate immune sensors, together with RLRs and NLRs. So far, 13 distinct mammalian TLRs have been identified 10 of which are functional in humans (TLR1-10), and 11 in mice (TLR1-7, TLR9, TLR11-13).
20,21 TLR1, 2, 4, 5, 6, 10 and 11 are located on the cell surface, whereas, TLR3, 7, 8 and 9 are located in the endosome. The high levels and broadest spectra of TLR expression have been observed in variety of cell types in the immune system, including monocytes/ macrophages, 23 TLRs can recognize a wide variety of PAMPs derived from bacteria, fungi, parasites and viruses, which were summarized in Table 2 with references . They act as homodimers or heterodimers of type I trans-membrane glycoproteins, each comprising a ligand-binding ectodomain con- TLR extodomain has a typical horseshoe-shaped solenoid structure. The inner surface of concave is mostly formed by parallel b-strands and the outer surface of convex has various secondary structural elements, such as loops of different lengths, a-helices and right-handed helical structures. Crystal structure analyses suggest that TLR agonists can promote TLR dimerization by stabilizing the interaction between the C termini of the horseshoe-shaped modules, followed by trigger of signaling. The cytoplasic TLR domain displays a compact globular confirmation formed by five parallel b-strands and five a helices connected by flexible loops. 78, 79 To the contrary, no crystal structures of TLR-DAMP complex have been reported yet.
DAMP RECOGNITION BY TLRs
TLRs can recognize not only exogenous PAMPs, but also DAMPs of endogenous molecules. Intracellular molecules released into the extracellular milieu by activated and necrotic cells, as well as extracellular matrix molecules either up- regulated or degraded by tissue injury, sterile inflammation and degeneration. They all have potential to work as DAMPs. Definite, probable or possible endogenous TLR ligands of DAMP have been also reported and can be categorized as proteins/peptides, fatty acid/lipoproteins, proteoglycan/glycosaminoglycans, and nucleic acids/protein-nucleic acids complex, which was summarized by Piccinini and Midwood.
7 Proteins/peptides include ; b-defensin-3 for TLR1, HSP60, HSP70, gp96, HMGB1, HMGB1-nucleosome complex, b-defensin-3, surfactant proteins, eosinophilderived neurotoxin, and antiphospholipid antibodies for TLR2, HMGB1, fibronectin EDA, fibrinogen, tenascin C, surfactant proteins, b-defensin-3, HSP60, HSP70, HSP72, HSP22 (B8), gp96, S100A8 (Mrp8), S100A9 (Mrp14), neutrophil elastase, antiphospholipid antibodies, and lactoferrin for TLR4, antiphospholipid antibodies for TLR7 and TLR8. Fatty acids/lipoproteins include ; serum amyloid A for TLR2, serum amyloid A, oxidized LDL, and saturated fatty acid for TLR4. Proteoglycans/glycosaminoglycans include ; biglycan, versican, and hyaluronic acid fragments for TLR2, biglycan, heparan sulfate fragments, and hyaluronic acid fragments for TLR4. Nucleic acids/protein-nucleic acid includes dsRNA for TLR3, ssRNA for TLR7 and TLR8, and IgGchromatin complexes for TLR9. Thus, TLRs can react with both PAMPs and DAMPs, and represent a key molecular link among microbial infection, tissue injury, sterile inflammation and degeneration. Crystal structure analyses have proposed possible diverse modes of exogenous ligand recognition by TLRs, involving TLR homodimerization and heterodimerization, as well as direct TLR-ligand interactions or interactions with co-receptors and accessory molecules.
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CO-RECEPTORS AND ACCESSORY MOLECULES
Co-receptors and accessory molecules are known to assist PAMP recognition together with some TLRs, 80 ,82 e.g., MD-2, CD14, Mrp8, RP105 and PAR-2 for TLR4 homodimer, and CD14, CD36 and dectin for heterodimers of TLR1-TLR2 and TLR1-TLR6. [83] [84] [85] MD-2 and CD14 can work to assist DAMP recognitions, independently or together. 7 In addition, P2X4/ P2X7 was shown to activate TLR2 and TLR4 by ligand stimulation of biglycan in macrophages.
14 HMGB1 mediates activation of plasmacytoid DCs and B cells through TLR9 by DNA-containing immune complexes with immunoglobulin superfamily member RAGE. 86 CD44, together with MD-2, can assist recognition of hyaluronic acid by TLR4. 
TLRs AND THE ADAPTORS FOR SIGNALING
The initial role of TLRs is to function as sensors for danger signals of PAMPs and also bind DAMPs to initiate innate host responses. 19, 20, 67 Binding of TLR ligands to the receptor triggers conformational rearrangements of the cytoplasmic TIR domains and recruitment of specific adaptors via homotype TIR-TIR interactions. The main adaptor molecules include MyD88, TRIF (also known as TICAM-1), TIRAP (also known as Mal), and TRAM (also known as TICAM-2). 88, 89 MyD88 and TRIF are main adaptors. Most TLRs use MyD88. TLR4 uses both MyD88 and TRIF, and TLR3 uses TRIF. In spite of direct interaction of intracellular portion of TLRs with MyD88 or TRIF, TLR1, 2, 4 and 6, which are located in the plasma membrane, require additional adaptors for the signaling to down-stream; e.g., TIRAP for MyD88, and TRAM for TRIF. Interaction of adaptor molecules are followed by recruitment of kinases and ubiquitn ligases, thus leading to activation and nuclear translocation of several transcription factors, such as NF-kB, AP1 and IRF 3/7, which was dependant on the cell types of innate immune system 5, 77, 90 ( Fig. 2a and 2b) .
Ligand-TLR interactions lead to up-regulation of proinflammatory cytokines, chemokines, and chemokine receptors, such as TNF-a, 91 TLR-ligand interactions also up-regulate co-stimulatory molecules, such as intercellular adhesion molecule-1, 92 lymphocyte function-associated antigen-1 and -3. 94 Co-stimulatory molecules are essential for the induction of pathogen-specific adaptive immune responses. 97 Thus, TLRs link innate host responses to adaptive immunity.
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INHIBITORY REGULATORS AND POSSIBLE MEHANISM FOR TLR SIGNALING
Immune system needs to constantly strike a balance between activation and inhibition to escape from detrimental and inappropriate inflammatory responses as well as inadequate and lower host defense. TLR system must be tightly regulated both in physiologic and pathologic states, otherwise, either insufficient or excessive reactions endanger the host severe or lethal events in microbial infections. Furthermore, immune-mediated aseptic inflammatory diseases are evoked. Negative regulators of TLR signaling have been reported, which may affect the pathway at the levels of extracellular space, cell membrane, cytosol and endosome. 77, 87, [100] [101] [102] Currently known negative regulators and the candidates, together with their corresponding TLRs and posible inhibitory mechanisms, are listed in Table 3 with references (103-136). The possible regulators include EGCG and soluble TLR2/4 in the extracellular space, TMED1, TRAILR and SIGIRR on the cell membrane, and A20, BCAP-L, EGCG, IRAKM, IRF4, MSK1, MSK2, NOD2, PI3K, SHIP-1, SOCS1, symvastatin, TANK, TcpB, TcpC, TOLLIP, Triad3A, TRIB1, TRIB3 and VV protein A46R in the cytoplasm, and chroloquine, citalopram, fluoxetine, and NC-2300 in the endosme.
In each binding process of TLR and ligand, it is interesting and noteworthy that PAMPs and DAMPs may have potential to occupy the same or neighboring biding sites on TLRs to modulate the reaction each other. For example, surfactant protein A was shown to bind extracellular domain of TLR2 and down-regulate induction of NF-kB and TNF-a secretion, competing the same receptor with peptidoglycan and zymosan. 137, 138 This suggests possible interaction between the different ligands, which can bind to same receptors, leading to modification of activated signal pathways depending type, amount and distribution of the ligands both in physiological and pathologic conditions. Complex of TLR-like molecule, RP105 and MD-1 can acts as TLR4 decoy receptor. They can inhibit TLR4 activation to compete the receptor with microbial ligands in DCs. 139 Cathepsin K inhibitor, NC-2300 and disease-modifying anti-rheumatic drug, chloroquine, showed inhibitory effect of TLR9-CpG DNA interaction in DCs. 135 Selective serotonin reuptake inhibitors have been known to have anti-inflammatory effect, which was confirmed by systemic administration of fluoxetine and citalopam to suppress the signaling of endosomal TLR3, 7 and 9 in murine collagen-induced arthritis model and cell culture of macrophages and fibroblasts.
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EXPERIMENTAL ARTHRITIS INDUCED BY PAMPs AND DAMPs
Experimental models of acute and chronic synovitis indicated the relevant pathogenesis via TLRs and their ligands. Systemic injection of streptococcal cell wall could induce arthritis, 140 which has been followed by numerous studies using PAMPs to evoke arthritis in animal models. Microbesderived TLR ligands, such as peptideglycan for TLR2, 141 dsRNA via TLR3, 142 LPS for TLR4 143 and CpGDNA for TLR9 144 have frequently been used for to provoke or accelerate experimental arthritis. TLR4 was reported to be involved in the chronicity and erosive destruction of streptococcal cell wall-induced arthritis, which was coincident with the antigenspecific IL-17 response. 145 DAMP can also induce arthritis. Endogenous mitochondrial DNA, containing unmethylated CpG motifs and oxidatively damaged products, could evoke arthritis by monocyte/ macrophages, but not B cells or T cells. 146 Intraarticular injection of tenascin-C promoted joint inflammation in vivo in mice. Mice that did not express tenascin-C showed rapid resolution of acute joint inflammation and were protected from erosive arthritis. The synthesis and tissue expression were induced in myeloid cells upon tissue injury or infection Thus, tenascin-C acted as TLR4 activator and novel autocrine loop in the arthritis. 147, 148 S100A8 is a strong promoter of activating FcgRI and FcgRIV in macrophages through the activation of TLR4 and act as a regulator of FcgR expression in inflamed synovium in chronic experimental arthritis.
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TLRs AND THE ADAPTORS IN RA SYNOVIAL TISSUES
Synovial tissues from RA joints expressed TLR2 predominantly at sites of attachment and invasion into cartilage and bone, mostly in synovial fibroblasts, but not in macrophages, which expression was enhanced not only by IL-1b and TNFa, but also LPS. 150 Immunoractivities of TLR2, 91, 150, 151 TLR3, 151, 152 TLR4 91, 151 and TLR7 152 were demonstrated in RA synovial lining and sublining, but the precise cellular identification was not done. In RA synovium of early stage, increased expression of TLR3 and TLR4 were demonstrated as well as that of TLR2, 3 and 4 in long-lasting RA synovitis. 153 Current analyses using double immunofluorescent staining revealed tissue localization of TLR1, 2, 3, 4, 5, 6 and 9, as well as adaptor molecules in inflamed rheumatoid synovium. TLR1, 2, 3, 4, 5, 6, 9, MyD88, TIRAP/Mal and TRIF/TICAM-1 were strongly labeled in DCs both of myeloid and plasmacytoid types, moderately in type A macrophage-like lining cells/ intimal macrophages and weakly-to-moderately in type B fibroblast-like lining cells/intimal fibroblasts. CD3 + /CD4 + and CD3 + /CD8 + T cells and CD20 + B cells in perivenular areas and in lymphoid follicles were moderately TLRs and weakly adaptor positive. In osteoarthritic synovium, TLRs and the adaptors were only very weakly immuno-labeled in vascular, lining and inflammatory cells. 36 Taken together, the data suggested that RA synovium well-equipped with TLRs and adaptors, which implies high and prompt responsiveness to the external and internal stimuli, namely, PAMPs and DAMPs.
In vitro analyses on TLRs of peripheral blood mononuclear cells demonstrated that TLR1 was expressed monocytes, polymorphonuclear leukocytes, B cells, T cells and NK cells. TLR2, 4 and 5 were expressed in myelomonocytic elements. TLR3 was only expressed in DCs, wherein maturation induced by bacterial products or cytokines was associated with reduced expression. 29 Same type of analyses revealed that TLR1 and TLR6 were expressed in all cell types of monocytes, plasmacytoid DCs, B cells, NK cells and T cells in peripheral blood. Evident expression of TLR2, 4 and 5 in monocytes, and that of TLR7 and 9 with high responsiveness to CpG DNA were observed. 26 In addition, DCs in blood sample expressed TLR1, 2, 3, 4, 5, 6 and 8 in myeloid type, and TLR7 and 9 in plasmacytoid type. 154 Immature monocytic DCs of blood expressed TLR1, 2, 3, 4 and 5, but evidently expressed TLR3 with decrease of TLR1, 2, 4 and 5 after maturation induced by LPS. 24 Monocytes/macrophages derived from bone marrow showed expression of TLR2, 4, 5 and 9.
TLRs in Rheumatoid Arthritis
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27,28 Embryonic fibroblasts showed potential to have responsiveness to various type of ligands via TLR1, 2, 3, 4, 5, 6, 7, 8 and 9. Thus, when compared with mesenchymal cell types, hematopoietic cell types showed relatively restricted presentation of TLRs. There is discrepancy between immunohistochemical analyses and in vitro experiments. In addition to the presence of immunoreactive cells of TLR2 and 4 91 as well as those of TLR 3 and 7 152 in synovial lining and sublining intima, well equipment of TLR1, 2, 3, 4, 5, 6 and 9 in monocytes/macrophages, DCs, B cells and T cells in RA synovium were observed by immunohistochemisty. 36 Marked inflammation in RA synovium can produce a variety of mediators and DAMPs, which may influence expression of TLRs in the diseased tissues, being with various states of maturation and/or activation of each cell type. Thus, it may contribute to different profiles of TLR expressions between inflamed RA tissues and in vitro studies with blood samples. It would be studied precisely, with careful further evaluation of the specificity of the antibodies used in immunohistochemistry. Embryonic fibroblasts, 38 cell lines 155 and cancer cells were also known to display various types of TLR. 156 It is important to study how different vital circumstances affect expression of TLRs in cell types and tissues, as well as examination of the difference between in vivo and in vitro.
PAMPs AND DAMPs IN RA SYNOVIAL TISSUES
Possible infectious causes of RA have been long suggested by potential pathogenetic mechanisms; mycoplasma by direct synovial infections and super antigens, parvovirus B19 and retrovirus by direct synovial infection, enteric bacteria and Epstein-Bar virus by molecular mimicry of QKRAA of HLA-DR b1 region, mycobacterium by molecular mimicry of proteoglycans, QKRAA and immunostimulatory DNA, and bacterial cell wall by macrophage activation. 157 Anaerobic bacterial DNA and high levels of antibodies against these bacteria have been detected in the serum and synovial fluid from patients with early and late stage of RA. 158, 159 Oral bacteria, such as prophyromonas gingivalis by molecular mimicry of citrullinated enolase, has been suggested to be involved in triggering of the disease. 160 Apart from such possible combined effect of genetic and environmental factors, there is also increasing awareness that innate immune system could directly contribute to onset and lasting course of RA. High percentage of bacterial DNA was detected in the RA and reactive arthritis patients. 161 In addition, bacterial peptideglycans was demonstrated in the synovial macrophages. 162 Exogenous PAMPs can evoke initial immune response via TLRs, which has been implicated to be involved in triggering of joint inflammation and disease flares in RA.
In RA synovial tissues and/or fluid, several DAMPs have been suggested to act as stimulators of TLRs ; biglycan, 12, 13, 163 fibrinogen, 164, 165 fibronectin EDA (FENDA), 166, 167 HMGB1, 168 HSP70, 169, 170 HSP B8 (HSP22), 171 low molecular weigh hyarulonic acid, 172, 173 S100A8/9 174-176 and tenascin-C. 148, [177] [178] [179] These molecules have potential to stimulate TLRs, thus evoke and/or enhance innate immune system, and couple with adoptive immune reaction in RA.
CONCLUSION
Extensive research revealed that identification of receptors, ligands and the molecular pathway on TLR system have contributed to better understanding of the pathogenesis of RA and allied arthritic conditions. Further analyses on the interplay between TLRs and other innate sensors, combined with inhibitory mechanisms by negative regulators, would provide more precious information on arthritis responsible for inflammation and joint destruction induced by not only autoimmune and autoinflammatory responses, but also infection and sterile degeneration. This will be beneficial for the diagnostic and therapeutic strategies, and also contribute to prevention or progress of the diseases. 
